Over Half of Cardiology Patients May Qualify for Semaglutide Under New Guidelines
Real-world registry data shows 54% of coronary artery disease patients meet eligibility criteria for semaglutide based on SELECT and SOUL trial standards.
Cardiovascular disease prevention, blood pressure, cholesterol, and heart function
671 articles
Real-world registry data shows 54% of coronary artery disease patients meet eligibility criteria for semaglutide based on SELECT and SOUL trial standards.
A new nanoparticle system delivers rapamycin and a DNA scavenger directly to arterial plaques, cutting inflammation and improving plaque stability in mice.
NEJM experts review antidotes for reversing anticoagulants during major bleeding or emergency surgery — a critical gap in modern medicine.
OpenAI's Karan Singal explains how AI tools like ChatGPT for Clinicians are reshaping how patients and doctors access medical knowledge.
A new randomized trial tests whether one combined antihypertensive pill can prevent recurrent strokes after intracerebral hemorrhage.
New VA database analysis sheds light on the contested link between GLP-1 receptor agonists and pancreatitis risk.
Cardiologist Dr. Pradip Jamnadas explains how fat stored around organs drives inflammation and metabolic disease.
Chronic stress rewires your nervous system as the new default. Learn how slow breathing activates the vagus nerve to restore calm.
Dr. Pradip Jamnadas shares what thousands of patient cases taught him about visceral fat and cardiovascular disease prevention.
Dr. Jamnadas explores why some patients bounce back from surgery while others struggle — and the physiological balance that makes the difference.
Cardiologist Dr. Jamnadas explains why severe arterial blockages often cause no symptoms until a heart attack strikes.
Every meal feeds trillions of gut bacteria. Dr. Jamnadas explains how different fibers build a diverse, resilient microbiome.